Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

R. Suzuki, T. Hideshima, N. Mimura, J. Minami, H. Ohguchi, S. Kikuchi, Y. Yoshida, Gullu Gorgun, D. Cirstea, F. Cottini, J. Jakubikova, Y. T. Tai, D. Chauhan, P. G. Richardson, N. C. Munshi, T. Utsugi, K. C. Anderson

Research output: Contribution to journalArticle

17 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)510-514
Number of pages5
JournalLeukemia
Volume29
Issue number2
DOIs
StatePublished - Feb 7 2015
Externally publishedYes

Fingerprint

Neoplasm Transplantation
Antitumor Drug Screening Assays
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Pyrazoles
Boronic Acids
Pyrazines
HSP90 Heat-Shock Proteins
SCID Mice
Monomeric GTP-Binding Proteins
Retinal Pigment Epithelium
Tumor Cell Line
Multiple Myeloma
Antineoplastic Agents
Cell Survival
Cell Proliferation
Apoptosis
Cell Line
Mutation
Neoplasms

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Suzuki, R., Hideshima, T., Mimura, N., Minami, J., Ohguchi, H., Kikuchi, S., ... Anderson, K. C. (2015). Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. Leukemia, 29(2), 510-514. https://doi.org/10.1038/leu.2014.300

Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. / Suzuki, R.; Hideshima, T.; Mimura, N.; Minami, J.; Ohguchi, H.; Kikuchi, S.; Yoshida, Y.; Gorgun, Gullu; Cirstea, D.; Cottini, F.; Jakubikova, J.; Tai, Y. T.; Chauhan, D.; Richardson, P. G.; Munshi, N. C.; Utsugi, T.; Anderson, K. C.

In: Leukemia, Vol. 29, No. 2, 07.02.2015, p. 510-514.

Research output: Contribution to journalArticle

Suzuki, R, Hideshima, T, Mimura, N, Minami, J, Ohguchi, H, Kikuchi, S, Yoshida, Y, Gorgun, G, Cirstea, D, Cottini, F, Jakubikova, J, Tai, YT, Chauhan, D, Richardson, PG, Munshi, NC, Utsugi, T & Anderson, KC 2015, 'Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma', Leukemia, vol. 29, no. 2, pp. 510-514. https://doi.org/10.1038/leu.2014.300
Suzuki, R. ; Hideshima, T. ; Mimura, N. ; Minami, J. ; Ohguchi, H. ; Kikuchi, S. ; Yoshida, Y. ; Gorgun, Gullu ; Cirstea, D. ; Cottini, F. ; Jakubikova, J. ; Tai, Y. T. ; Chauhan, D. ; Richardson, P. G. ; Munshi, N. C. ; Utsugi, T. ; Anderson, K. C. / Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. In: Leukemia. 2015 ; Vol. 29, No. 2. pp. 510-514.
@article{537d5168249c47799be62b6dee9d00ff,
title = "Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma",
author = "R. Suzuki and T. Hideshima and N. Mimura and J. Minami and H. Ohguchi and S. Kikuchi and Y. Yoshida and Gullu Gorgun and D. Cirstea and F. Cottini and J. Jakubikova and Tai, {Y. T.} and D. Chauhan and Richardson, {P. G.} and Munshi, {N. C.} and T. Utsugi and Anderson, {K. C.}",
year = "2015",
month = "2",
day = "7",
doi = "10.1038/leu.2014.300",
language = "English (US)",
volume = "29",
pages = "510--514",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

AU - Suzuki, R.

AU - Hideshima, T.

AU - Mimura, N.

AU - Minami, J.

AU - Ohguchi, H.

AU - Kikuchi, S.

AU - Yoshida, Y.

AU - Gorgun, Gullu

AU - Cirstea, D.

AU - Cottini, F.

AU - Jakubikova, J.

AU - Tai, Y. T.

AU - Chauhan, D.

AU - Richardson, P. G.

AU - Munshi, N. C.

AU - Utsugi, T.

AU - Anderson, K. C.

PY - 2015/2/7

Y1 - 2015/2/7

UR - http://www.scopus.com/inward/record.url?scp=84922457791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922457791&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.300

DO - 10.1038/leu.2014.300

M3 - Article

C2 - 25306900

AN - SCOPUS:84922457791

VL - 29

SP - 510

EP - 514

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -